Amitriptyline and Leuprolide: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Amitriptyline
Leuprolide
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines can affect the timing of your heartbeat. Amitriptyline (Elavil) is known to slightly stretch out part of the heart's electrical cycle, called the QT interval. Leuprolide (like Lupron or Eligard) lowers certain hormones, and that can also stretch the QT interval. Taken together, the two effects can add up, which in rare cases could lead to an irregular heartbeat.
The good news is this is mostly a theoretical concern, and your care team can manage it well. They may check an ECG and your blood minerals (like potassium and magnesium) from time to time. Keep taking both as prescribed and talk with your doctor or pharmacist before making any changes.
Effect: Additive risk of QT/QTc prolongation.
Mechanism: Amitriptyline (a TCA) prolongs QT via cardiac potassium channel effects; leuprolide prolongs QTc secondary to androgen deprivation. The result is additive QT prolongation (a pharmacodynamic interaction, not metabolic; neither drug's clearance is altered here).
Evidence: Theoretical. Severity: Major. Onset: Unspecified.
Management:
- Weigh benefits of androgen deprivation therapy against arrhythmia risk; avoid the combination when feasible.
- If coadministered, correct and avoid hypokalemia/hypomagnesemia.
- Obtain periodic ECG and electrolyte monitoring.
- Review other QT-prolonging agents and dose individualization by the care team.
What happens
Increased risk of QT interval prolongation
Interaction Deep Dive
By producing androgen deprivation, leuprolide can lengthen the QT/QTc interval. In patients receiving medications recognized to prolong the QT interval, weigh whether the advantages of androgen deprivation therapy justify the possible hazards34. Where feasible, refrain from combining leuprolide with QT prolonging agents. Should coadministration be necessary, steer clear of medications that produce electrolyte disturbances (that is, hypokalemia or hypomagnesemia)1, and think about periodic ECG and electrolyte monitoring34.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
You can usually take both medicines together safely when your care team keeps an eye on things. Here is what they typically do:
- Decide whether the benefit of leuprolide therapy outweighs the small added heart-rhythm risk in your case.
- Check an ECG and your electrolytes (potassium and magnesium) from time to time.
- Keep your minerals in a healthy range, since low levels can raise the risk.
What you should do: keep taking both exactly as prescribed, and tell your pharmacist or doctor if you feel fainting, palpitations, or a fluttering heartbeat. The dose and monitoring plan may be adjusted and individualized by your care team.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In an analysis of male patients receiving androgen deprivation therapy (ADT) using individual case safety reports from VigiBase, the international pharmacovigilance database, investigators identified 184 cases of acquired long-QT syndrome (aLQTS) and/or torsades de pointes (TdP; 11% fatal cases), along with 99 cases of sudden death linked to ADT. The majority of aLQTS/TdP cases (62%) and sudden death cases (88%) associated with ADT arose without concurrent use of other agents known to raise TdP risk; nevertheless, some aLQTS/TdP events (23% or 43%) and sudden death events (18% and 22%) involved use of 1 drug and 2 or more drugs with conditional, possible, or known TdP risk. The agents regarded as ADTs included abiraterone, gonadotropin-releasing hormone agonists and antagonists, nonsteroidal androgen receptor inhibitors indicated for prostate cancer, and 5-alpha-reductase inhibitors indicated for androgenic alopecia and prostatism. Among the 10 ADTs assessed, 7 showed a disproportional association (reporting odds ratio, 1.4 to 4.7) with aLQTS, TdP, or sudden death, namely leuprorelin, goserelin, triptorelin, degarelix, bicalutamide, finasteride, and dutasteride. The median patient age was approximately 76 years, and the median time to onset was 170 days (range, 7 to 4884 days) for aLQTS/TdP events and 92 days (range, 0.25 to 4984 days) for sudden death events. Patients were primarily taking ADT to treat prostate cancer, with some using therapy for prostatism and androgenic alopecia. Most patients were on ADT monotherapy (83%); 17% were receiving ADT combination therapy 2.
Common questions
Can I take Amitriptyline and Leuprolide together?
Combining amitriptyline and leuprolide can add up to a longer QT interval, so your care team may monitor your ECG and electrolytes; keep taking both as prescribed and report any fainting or palpitations. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Amitriptyline and Leuprolide interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Amitriptyline and Leuprolide interaction managed?
You can usually take both medicines together safely when your care team keeps an eye on things. Here is what they typically do: Decide whether the benefit of leuprolide therapy outweighs the small added heart-rhythm risk in your case. Check an ECG and your electrolytes (potassium and magnesium) from time to time. Keep your minerals in a healthy range, since low levels can raise the risk. What you… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Amitriptyline or Leuprolide need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Lyon AR, Lopez-Fernandez T, Couch LS, et al: 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 2022; 43(41):4229-4361.
- Salem JE, Yang T, Moslehi JJ, et al: Androgenic effects on ventricular repolarization: a translational study from the international pharmacovigilance database to iPSC-cardiomyocytes. Circulation 2019; 140(13):1070-1080. PubMed
- Product Information: CAMCEVI ETM subcutaneous emulsion, leuprolide subcutaneous emulsion. Foresee Pharmaceuticals (per FDA), Newark, DE, 2025. DailyMed
- Product Information: ELIGARD(R) subcutaneous injection suspension, leuprolide acetate subcutaneous injection suspension. Tolmar Pharmaceuticals, Inc. (per FDA), Fort Collins, CO, 2016. DailyMed
Keep reading about Amitriptyline
Keep reading about Leuprolide
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist